Osaic Holdings
ABEO icon

Osaic Holdings’s Abeona Therapeutics ABEO Stock Holding History

Osaic Holdings’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.41K Sell
1,431
-470
-25% -$2.35K ﹤0.01% 6548
2025
Q4 		$10K Buy
1,901
+952
+100% +$4.79K ﹤0.01% 6353
2025
Q3 		$6.21K Sell
949
-952
-50% -$6.04K ﹤0.01% 6631
2025
Q2 		$10.8K Buy
1,901
+1,532
+415% +$8.72K ﹤0.01% 6101
2025
Q1 		$1.75K Buy
369
+174
+89% +$946 ﹤0.01% 6649
2024
Q4 		$1.09K Sell
195
-13,798
-99% -$84.9K ﹤0.01% 6821
2024
Q3 		$88.4K Buy
13,993
+2,181
+18% +$11.4K ﹤0.01% 4318
2024
Q2 		$50K Buy
11,812
+10,707
+969% +$54.6K ﹤0.01% 4674
2024
Q1 		$8.01K Sell
1,105
-1,500
-58% -$9.51K ﹤0.01% 5875
2023
Q4 		$13.1K Sell
2,605
-65
-2% -$286 ﹤0.01% 5700
2023
Q3 		$11.2K Buy
2,670
+65
+2% +$246 ﹤0.01% 5861
2023
Q2 		$10.5K Hold
2,605
– – ﹤0.01% 5926
2023
Q1 		$7.35K Buy
2,605
+1,500
+136% +$3.92K ﹤0.01% 6148
2022
Q4 		$3K Sell
1,105
-392
-26% -$1.47K ﹤0.01% 6473
2022
Q3 		$4K Sell
1,497
-1
-0.1% -$4 ﹤0.01% 6447
2022
Q2 		$7K Buy
1,498
+1,432
+2,170% +$7.24K ﹤0.01% 6284
2022
Q1 		$1K Hold
66
– – ﹤0.01% 6975
2021
Q4 		$1K Hold
66
– – ﹤0.01% 7119
2021
Q3 		$2K Hold
66
– – ﹤0.01% 6818
2021
Q2 		$3K Hold
66
– – ﹤0.01% 6563
2021
Q1 		$3K Buy
+66
New +$3.64K ﹤0.01% 6333

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Osaic Holdings's ABEO Position: Q1 2026 in Review

Osaic Holdings reduced its Abeona Therapeutics (ABEO) stake by 25% in Q1 2026, selling an estimated $2.35K and leaving 1,431 shares worth $6.41K. The position accounts for ﹤0.01% of the portfolio, ranked #6548.

Osaic Holdings first reported a position in ABEO in Q1 2021 and has held it in 21 quarters since. The position peaked at $88.4K in Q3 2024. 108 funds tracked by Wall St. Rank hold ABEO as of Q1 2026.

  • Osaic Holdings held 1,431 shares of Abeona Therapeutics worth $6.41K as of Q1 2026.
  • Osaic Holdings sold 470 Abeona Therapeutics shares in Q1 2026, an estimated $2.35K.
  • Abeona Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #6548 holding.
  • Osaic Holdings first reported a position in Abeona Therapeutics in Q1 2021 and has held it in 21 quarters since.
  • Osaic Holdings's Abeona Therapeutics position peaked at $88.4K in Q3 2024.
  • 108 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.